Prevalence of HPV-DNA and Anti-HPV Antibodies in Women From Girardot, Colombia

Abstract

Peptides 18283, 18294, and 18301 were more specific and more sensitive than VLPs for detecting women with HR-HPV-DNA positive cervical lesions. Therefore, they could be useful in the design of a serological test for detecting HR-HPV-infected women having cervical lesions at a risk of progressing to cervical cancer.

Seroprevalence and awareness of human papillomavirus infection and cervical cancer screening results among reproductive-aged Georgian women

“…Studies from developing countries show higher rates of HPV seropositivity 19. In Colombia and South Africa the seroprevalence of HPV-16 alone was nearly 45% among women, which is much higher than the present study result 20 21…”

Age-Specific Human Papillomavirus Antibody and Deoxyribonucleic Acid Prevalence: A Global Review

“…HPV 16 seroprevalence varied greatly between different populations but were generally higher than in other world regions with an approximate average around 25% across all ages. Age trends seemed remarkably flat across age groups; in one Colombian study, HPV 16 seroprevalence was over 40% regardless of age (113). However, in general HPV 16 seroprevalence levels did increase slightly from age 18 years to age 30-40 years with several studies showing decreases in later years (16,110).…”

Age-Specific Seroprevalence of Human Papillomavirus 16, 18, 31, and 58 in Women of a Rural Town of Colombia

“…These observations are within the broad range found in previous reports but slightly higher than those reported for women younger than 24 years in other Latin American countries 15 and in Colombia. 16 The high rate of HPV exposure in the absence of an increased number of sexual partners may reflect continuing sexual exposure through the male partners. It has been shown that vaccination does not reduce progression to HPV-16/18Yrelated high-grade cervical lesions in women who are seropositive and DNA positive to HPV-16 or HPV-18 prevaccination.…”